RxDoctor Payments Data

Todd Stitik, MD

Pain Medicine · Newark, NJNPI 1356361349

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (46.1%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 17 manufacturers reported payments, led by Merz Pharmaceuticals, LLC at 38.7% of the total. Among pain medicine clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$370,058in general payments, 2019–2025

Across 298 payments — averaging $1241.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merz Pharmaceuticals, LLC$143K
  • Konica Minolta Healthcare Americas, Inc$102K
  • GE HealthCare$72K
  • AbbVie$17K
  • IBSA Pharma Inc.$15K
  • Fidia Pharma USA Inc.$8K
  • plus $12K from 11 others

What the payments were for

  • Consulting fees$162,35744%
  • Speaking & faculty fees$170,50346%
  • Travel & lodging$33,9449%
  • Food & beverage$3,2551%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$370,058 in reported general payments places this provider in the 95th percentile of 256 pain medicine providers in New Jersey.

See all pain medicine providers in New Jersey

Medicare billing

Part B allowed, 2024
$54,483
Medicare patients
84
Services billed
585

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Lidocaine17$1,265
Gabapentin66$810
Fentanyl13$642
Oxycodone Hcl33$463
Tramadol Hcl52$309
Pregabalin16$199
Morphine Sulfate12$122
Hydromorphone Hcl12$121
Acetaminophen-CodeineAcetaminophen With Codeine21$117
Tizanidine Hcl13$106
Morphine Sulfate ErMorphine Sulfate12$84
Baclofen16$71
Alprazolam15$10

Paid to pharmacies, not to this prescriber.

Other pain medicine in Newark

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →